Back to Search
Start Over
Supplementary Figure 1 from Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file - 66KB, OP449 in combination with ABL1 tyrosine kinase inhibitors inhibits BCR-ABL1 signaling in CML cells and cellular growth of primary CML blastic phase cells ex vivo.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....830b82e66872d9485d6e2120654cf440
- Full Text :
- https://doi.org/10.1158/1078-0432.22449390.v1